Genitourinary Drugs Market Size, Share & Trends Report

Genitourinary Drugs Market Size, Share & Trends Analysis Report By Indication (Prostate, Ovarian, Bladder, Cervical Cancer, UTI & STD), By Product (Hormonal Therapy, Gynecological), By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-1-68038-285-3
Number of Pages: 110
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Genitourinary Drugs Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Prostate cancer
- Ovarian cancer
- Bladder cancer
- Cervical cancer
- Renal cancer
- Erectile dysfunction
- Urinary tract infections
- Urinary incontinence & overactive bladder
- Sexually transmitted diseases
- Interstitial cystitis
- Hematuria
- Benign prostatic hyperplasia
Genitourinary Drugs Product Outlook (Revenue, USD Million, 2018 - 2030)
- Urologicals
- Hormonal therapy
- Gynecological
- Anti-infectives
- Others
Genitourinary Drugs Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Genitourinary Drugs Market, Indication Outlook
    - Prostate cancer
    - Ovarian cancer
    - Bladder cancer
    - Cervical cancer
    - Renal cancer
    - Erectile dysfunction
    - Urinary tract infections
    - Urinary incontinence & overactive bladder
    - Sexually transmitted diseases
    - Interstitial cystitis
    - Hematuria
    - Benign prostatic hyperplasia
  - North America Genitourinary Drugs Market, Product Outlook
    - Urologicals
    - Hormonal therapy
    - Gynecological
    - Anti-infectives
    - Others
  - U.S.
    - U.S. Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - U.S. Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Canada
    - Canada Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Canada Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
- Europe
  - Europe Genitourinary Drugs Market, Indication Outlook
    - Prostate cancer
    - Ovarian cancer
    - Bladder cancer
    - Cervical cancer
    - Renal cancer
    - Erectile dysfunction
    - Urinary tract infections
    - Urinary incontinence & overactive bladder
    - Sexually transmitted diseases
    - Interstitial cystitis
    - Hematuria
    - Benign prostatic hyperplasia
  - Europe Genitourinary Drugs Market, Product Outlook
    - Urologicals
    - Hormonal therapy
    - Gynecological
    - Anti-infectives
    - Others
  - UK
    - UK Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - UK Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Germany
    - Germany Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Germany Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - France
    - France Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - France Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Italy
    - Italy Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Italy Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Spain
    - Spain Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Spain Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Sweden
    - Sweden Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Sweden Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Norway
    - Norway Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Norway Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Denmark
    - Denmark Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Denmark Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
- Asia Pacific
  - Asia Pacific Genitourinary Drugs Market, Indication Outlook
    - Prostate cancer
    - Ovarian cancer
    - Bladder cancer
    - Cervical cancer
    - Renal cancer
    - Erectile dysfunction
    - Urinary tract infections
    - Urinary incontinence & overactive bladder
    - Sexually transmitted diseases
    - Interstitial cystitis
    - Hematuria
    - Benign prostatic hyperplasia
  - Asia Pacific Genitourinary Drugs Market, Product Outlook
    - Urologicals
    - Hormonal therapy
    - Gynecological
    - Anti-infectives
    - Others
  - Japan
    - Japan Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Japan Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - China
    - China Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - China Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - India
    - India Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - India Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Australia
    - Australia Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Australia Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Thailand
    - Thailand Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Thailand Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - South Korea
    - South Korea Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - South Korea Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
- Latin America
  - Latin America Genitourinary Drugs Market, Indication Outlook
    - Prostate cancer
    - Ovarian cancer
    - Bladder cancer
    - Cervical cancer
    - Renal cancer
    - Erectile dysfunction
    - Urinary tract infections
    - Urinary incontinence & overactive bladder
    - Sexually transmitted diseases
    - Interstitial cystitis
    - Hematuria
    - Benign prostatic hyperplasia
  - Latin America Genitourinary Drugs Market, Product Outlook
    - Urologicals
    - Hormonal therapy
    - Gynecological
    - Anti-infectives
    - Others
  - Brazil
    - Brazil Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Brazil Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Mexico
    - Mexico Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Mexico Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Argentina
    - Argentina Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Argentina Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
- Middle East and Africa
  - Middle East and Africa Genitourinary Drugs Market, Indication Outlook
    - Prostate cancer
    - Ovarian cancer
    - Bladder cancer
    - Cervical cancer
    - Renal cancer
    - Erectile dysfunction
    - Urinary tract infections
    - Urinary incontinence & overactive bladder
    - Sexually transmitted diseases
    - Interstitial cystitis
    - Hematuria
    - Benign prostatic hyperplasia
  - Middle East and Africa Genitourinary Drugs Market, Product Outlook
    - Urologicals
    - Hormonal therapy
    - Gynecological
    - Anti-infectives
    - Others
  - South Africa
    - South Africa Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - South Africa Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Saudi Arabia
    - Saudi Arabia Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Saudi Arabia Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - UAE
    - UAE Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - UAE Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Kuwait
    - Kuwait Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Kuwait Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.